GGTase-II beta Antibody (B-8)
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0455020
- Awardee
- Santa Cruz Biorechnology, Inc.
- Contracting organization
- University of Virginia
- Cumulative value
- $312.34
About this award
Santa Cruz Biotechnology, Inc. has been awarded contract A207_PO-0455020 by the University of Virginia for the supply of laboratory reagents. The contract, effective July 7, 2026, has a cumulative value of $312. The primary deliverable under this purchase order is one unit of GGTase-II beta Antibody (B-8), a research-grade immunological reagent, priced at $312.34 per unit. Delivery is designated to Emily Baum at the contracting organization.
This contract represents a straightforward materials procurement transaction for the University of Virginia, located in Virginia. As a purchase order-based agreement, the contract provides the institution with essential laboratory supplies for research or diagnostic applications. The specific delivery location and end-use application fall within the University of Virginia's research infrastructure requirements. Santa Cruz Biotechnology, Inc., serving as the prime contractor, is responsible for fulfilling the complete delivery obligation under this award.
Line items
| Item | Total |
|---|---|
| GGTase-II beta Antibody (B-8) | $312.34 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0455020?
Contract A207_PO-0455020 was awarded to Santa Cruz Biorechnology, Inc. by University of Virginia on July 7, 2026.
How much is contract A207_PO-0455020 worth?
Its cumulative value is $312.34.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award